Zolpidem Tartrate
Product Images NDC 45865-956

3 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 45865-956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (956)

Pdp (956)
Zolpidem tartrate ER Tablets 12.5 mg packaging label from Medsource Pharmaceuticals. The label identifies the product as generic for Ambien CR, with 30 tablets per container. It notes possible side effects such as dizziness or drowsiness and advises avoiding alcohol. Lot and expiration date fields are also present for patient-specific information.*
FDA Label Image

Chemical Structure (Zolpidem 01)

Chemical Structure (Zolpidem 01)
Chemical structure diagram of Zolpidem tartrate. The image shows the molecular structure including the zolpidem part with aromatic and nitrogen-containing rings, and the tartrate component with carboxyl and hydroxyl groups.*
FDA Label Image

Figure 1 (Zolpidem 02)

Figure 1 (Zolpidem 02)
A pharmacokinetic curve comparing zolpidem tartrate plasma concentrations (ng/mL) over time (hours) for 12.5 mg extended-release and 10 mg immediate-release oral dosage forms. The graph shows concentration changes with time, illustrating different release profiles for the two formulations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.